Modestus Obochi

Modestus Obochi, PhD MBA, currently serves as the Chief Business Officer at Sernova Corp. and as an advisor at 2Flo Ventures, LLC, where involvement includes serving on the boards of various portfolio companies. Obochi is also a Board Member of Temprian Therapeutics. Previous experience includes roles such as EVP, Strategy & Business Development and General Manager at Phlow Corporation, and Managing Partner at TKC Alliance, LLC, where expertise was offered in maximizing pharmaceutical investments. Additional positions held encompass Strategy & Business Development Executive at Pfenex Inc., Global Vice President at Baxter International Inc., and Global Commercial Development & Launch Lead at Pfizer. Obochi has a robust educational background, with a PhD in Immunology from The University of British Columbia, an MBA in Strategic Management from Simon Fraser University, and an MSc in Nuclear Medicine & Radiobiology from Université de Sherbrooke, complemented by a B.Sc. in Biochemistry & Microbiology from the University of Nigeria, Nsukka.